Spontaneous mutations and the origin and maintenance of quantitative genetic variation

  1. Wen Huang
  2. Richard F Lyman
  3. Rachel A Lyman
  4. Mary Anna Carbone
  5. Susan T Harbison
  6. Michael M Magwire
  7. Trudy FC Mackay  Is a corresponding author
  1. North Carolina State University, United States
  2. Washington University in St. Louis, United States
  3. National Heart Lung and Blood Institute, United States
  4. Syngenta, United States

Abstract

Mutation and natural selection shape the genetic variation in natural populations. Here, we directly estimated the spontaneous mutation rate by sequencing new Drosophila mutation accumulation lines maintained with minimal natural selection. We inferred strong stabilizing natural selection on quantitative traits because genetic variation among wild-derived inbred lines was much lower than predicted from a neutral model and the mutational effects were much larger than allelic effects of standing polymorphisms. Stabilizing selection could act directly on the traits, or indirectly from pleiotropic effects on fitness. However, our data are not consistent with simple models of mutation-stabilizing selection balance; therefore, further empirical work is needed to assess the balance of evolutionary forces responsible for quantitative genetic variation.

Article and author information

Author details

  1. Wen Huang

    Program in Genetics, North Carolina State University, Raleigh, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Richard F Lyman

    Program in Genetics, North Carolina State University, Raleigh, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Rachel A Lyman

    Department of Biology, Washington University in St. Louis, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Mary Anna Carbone

    Program in Genetics, North Carolina State University, Raleigh, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Susan T Harbison

    Laboratory of Systems Genetics, National Heart Lung and Blood Institute, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Michael M Magwire

    Syngenta, Research Triangle Park, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Trudy FC Mackay

    Program in Genetics, North Carolina State University, Raleigh, United States
    For correspondence
    trudy_mackay@ncsu.edu
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Molly Przeworski, Columbia University, United States

Version history

  1. Received: January 21, 2016
  2. Accepted: May 21, 2016
  3. Accepted Manuscript published: May 23, 2016 (version 1)
  4. Version of Record published: June 16, 2016 (version 2)
  5. Version of Record updated: October 19, 2016 (version 3)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 10,555
    views
  • 722
    downloads
  • 61
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wen Huang
  2. Richard F Lyman
  3. Rachel A Lyman
  4. Mary Anna Carbone
  5. Susan T Harbison
  6. Michael M Magwire
  7. Trudy FC Mackay
(2016)
Spontaneous mutations and the origin and maintenance of quantitative genetic variation
eLife 5:e14625.
https://doi.org/10.7554/eLife.14625

Share this article

https://doi.org/10.7554/eLife.14625

Further reading

    1. Genetics and Genomics
    Mohammad Alfatah, Jolyn Jia Jia Lim ... Frank Eisenhaber
    Research Article

    Uncovering the regulators of cellular aging will unravel the complexity of aging biology and identify potential therapeutic interventions to delay the onset and progress of chronic, aging-related diseases. In this work, we systematically compared genesets involved in regulating the lifespan of Saccharomyces cerevisiae (a powerful model organism to study the cellular aging of humans) and those with expression changes under rapamycin treatment. Among the functionally uncharacterized genes in the overlap set, YBR238C stood out as the only one downregulated by rapamycin and with an increased chronological and replicative lifespan upon deletion. We show that YBR238C and its paralog RMD9 oppositely affect mitochondria and aging. YBR238C deletion increases the cellular lifespan by enhancing mitochondrial function. Its overexpression accelerates cellular aging via mitochondrial dysfunction. We find that the phenotypic effect of YBR238C is largely explained by HAP4- and RMD9-dependent mechanisms. Furthermore, we find that genetic- or chemical-based induction of mitochondrial dysfunction increases TORC1 (Target of Rapamycin Complex 1) activity that, subsequently, accelerates cellular aging. Notably, TORC1 inhibition by rapamycin (or deletion of YBR238C) improves the shortened lifespan under these mitochondrial dysfunction conditions in yeast and human cells. The growth of mutant cells (a proxy of TORC1 activity) with enhanced mitochondrial function is sensitive to rapamycin whereas the growth of defective mitochondrial mutants is largely resistant to rapamycin compared to wild type. Our findings demonstrate a feedback loop between TORC1 and mitochondria (the TORC1–MItochondria–TORC1 (TOMITO) signaling process) that regulates cellular aging processes. Hereby, YBR238C is an effector of TORC1 modulating mitochondrial function.